Microglia function in the central nervous system during health and neurodegeneration

Annual Review of Immunology

Volumn 35, Issue , 2017, Pages 441-468

  Colonna, Marco ^a   Butovsky, Oleg ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Homeostasis; Microglia; Neurodegeneration; Phenotypes; Receptors; Regulation

Indexed keywords

CYTOKINE; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; NEUROTRANSMITTER; PATHOGEN ASSOCIATED MOLECULAR PATTERN; PATTERN RECOGNITION RECEPTOR; TRANSCRIPTOME;

AGING; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANTIGEN PRESENTING CELL; ASTROCYTE; BRAIN DEVELOPMENT; CELL ACTIVATION; CELL DENSITY; CENTRAL NERVOUS SYSTEM FUNCTION; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; EXCITOTOXICITY; FUNCTIONAL CONNECTIVITY; GENDER; HEALTH; HUMAN; IMMUNE RESPONSE; MACROPHAGE; MENTAL DISEASE; MICROFLORA; MICROGLIA; MOLECULAR BIOLOGY; MONONUCLEAR PHAGOCYTE; NERVE CELL PLASTICITY; NERVE DEGENERATION; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; OPTIC NERVE DISEASE; PARKINSON DISEASE; PRION; PRION DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESTING STATE NETWORK; RETINA DISEASE; REVIEW; SYNAPSE; ANIMAL; BIOLOGICAL THERAPY; BRAIN; CENTRAL NERVOUS SYSTEM; HOMEOSTASIS; IMMUNOLOGY; METABOLISM; NEUROGENIC INFLAMMATION; PHYSIOLOGY; PROCEDURES; TRANSPLANTATION;

ANIMALS; BIOLOGICAL THERAPY; BRAIN; CENTRAL NERVOUS SYSTEM; CYTOKINES; HOMEOSTASIS; HUMANS; MICROGLIA; NEURODEGENERATIVE DISEASES; NEUROGENIC INFLAMMATION;

EID: 85018340947     PISSN: 07320582     EISSN: 15453278     Source Type: Book Series    
DOI: 10.1146/annurev-immunol-051116-052358     Document Type: Review

References (203)

1. Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, et al. 2010. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330:841-45
2. Schulz C, Gomez Perdiguero E, Chorro L, Szabo-Rogers H, Cagnard N, et al. 2012. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 336:86-90
3. Goldmann T, Wieghofer P, Jordao MJ, Prutek F, Hagemeyer N, et al. 2016. Origin, fate and dynamics of macrophages at central nervous system interfaces. Nat. Immunol. 17:797-805
4. Perdiguero EG, Geissmann F. 2016. The development and maintenance of resident macrophages. Nat. Immunol. 17:2-8
5. Dai XM, Ryan GR, Hapel AJ, Dominguez MG, Russell RG, et al. 2002. Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. Blood 99:111-20
6. Elmore MR, Najafi AR, Koike MA, Dagher NN, Spangenberg EE, et al. 2014. Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain. Neuron 82:380-97
7. Wang Y, Szretter KJ, Vermi W, Gilfillan S, Rossini C, et al. 2012. IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia. Nat. Immunol. 13:753-60
8. Greter M, Lelios I, Pelczar P, Hoeffel G, Price J, et al. 2012. Stroma-derived interleukin-34 controls the development and maintenance of Langerhans cells and the maintenance of microglia. Immunity 37:1050-60
9. Chitu V, Gokhan S, Nandi S, Mehler MF, Stanley ER. 2016. Emerging roles for CSF-1 receptor and its ligands in the nervous system. Trends Neurosci. 39:378-93
10. Lin H, Lee E, Hestir K, Leo C, Huang M, et al. 2008. Discovery of a cytokine and its receptor by functional screening of the extracellular proteome. Science 320:807-11
11. Ma X, Lin WY, Chen Y, Stawicki S, Mukhyala K, et al. 2012. Structural basis for the dual recognition of helical cytokines IL-34 and CSF-1 by CSF-1R. Structure 20:676-87
12. Nimmerjahn A, Kirchhoff F, Helmchen F. 2005. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308:1314-18
13. Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y, et al. 2005. ATP mediates rapid microglial response to local brain injury in vivo. Nat. Neurosci. 8:752-58
14. Wake H, Moorhouse AJ, Jinno S, Kohsaka S, Nabekura J. 2009. Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. J. Neurosci. 29:3974-80
15. TamWY, Ma CH. 2014. Bipolar/rod-shaped microglia are proliferating microglia with distinct M1/M2 phenotypes. Sci. Rep. 4:7279
16. Saijo K, Crotti A, Glass CK. 2013. Regulation of microglia activation and deactivation by nuclear receptors. Glia 61:104-11
17. Heneka MT, Golenbock DT, Latz E. 2015. Innate immunity in Alzheimer's disease. Nat. Immunol. 16:229-36
18. Wu J, Chen ZJ. 2014. Innate immune sensing and signaling of cytosolic nucleic acids. Annu. Rev. Immunol. 32:461-88
19. Sancho D, Reis e Sousa C. 2012. Signaling by myeloid C-type lectin receptors in immunity and homeostasis. Annu. Rev. Immunol. 30:491-529
20. Areschoug T, Gordon S. 2009. Scavenger receptors: role in innate immunity andmicrobial pathogenesis. Cell. Microbiol. 11:1160-69
21. Rebeck GW, LaDu MJ, Estus S, Bu G, Weeber EJ. 2006. The generation and function of soluble apoE receptors in the CNS. Mol. Neurodegener. 1:15
22. Lemke G. 2013. Biology of the TAM receptors. Cold Spring Harb. Perspect. Biol. 5:a009076
23. Fourgeaud L, Traves PG, Tufail Y, Leal-Bailey H, Lew ED, et al. 2016.TAM receptors regulatemultiple features of microglial physiology. Nature 532:240-44
24. Mizutani M, Pino PA, Saederup N, Charo IF, Ransohoff RM, et al. 2012. The fractalkine receptor but not CCR2 is present on microglia from embryonic development throughout adulthood. J. Immunol. 188:29-36
25. Jung S, Aliberti J, Graemmel P, Sunshine MJ, Kreutzberg GW, et al. 2000. Analysis of fractalkine receptor CX3CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol. Cell. Biol. 20:4106-14
26. Colonna M, Wang Y. 2016. TREM2 variants: new keys to decipher Alzheimer disease pathogenesis. Nat. Rev. Neurosci. 17:201-7
27. Linnartz-Gerlach B, Mathews M, Neumann H. 2014. Sensing the neuronal glycocalyx by glial sialic acid binding immunoglobulin-like lectins. Neuroscience 275:113-24
28. Wright GJ, Cherwinski H, Foster-Cuevas M, Brooke G, Puklavec MJ, et al. 2003. Characterization of the CD200 receptor family in mice and humans and their interactions with CD200. J. Immunol. 171:3034-46
29. Zhang H, Li F, Yang Y, Chen J, Hu X. 2015. SIRP/CD47 signaling in neurological disorders. Brain Res. 1623:74-80
30. Goldmann T, Blank T, Prinz M. 2016. Fine-tuning of type I IFN-signaling in microglia-implications for homeostasis, CNS autoimmunity and interferonopathies. Curr. Opin. Neurobiol. 36:38-42
31. Pocock JM, Kettenmann H. 2007. Neurotransmitter receptors on microglia. Trends Neurosci. 30:527-35
32. Taylor DL, Jones F, Kubota ES, Pocock JM. 2005. Stimulation of microglial metabotropic glutamate receptor mGlu2 triggers tumor necrosis factor a-induced neurotoxicity in concert with microglialderived Fas ligand. J. Neurosci. 25:2952-64
33. Hagino Y, Kariura Y, Manago Y, Amano T, Wang B, et al. 2004. Heterogeneity and potentiation of AMPA type of glutamate receptors in rat cultured microglia. Glia 47:68-77
34. Appel SH, Zhao W, Beers DR, Henkel JS. 2011. The microglial-motoneuron dialogue in ALS. Acta Myol. 30:4-8
35. Sica A, Mantovani A. 2012. Macrophage plasticity and polarization: in vivo veritas. J. Clin. Investig. 122:787-95
36. Wes PD, Holtman IR, Boddeke EW, Moller T, Eggen BJ. 2016. Next generation transcriptomics and genomics elucidate biological complexity of microglia in health and disease. Glia 64:197-213
37. Butovsky O, Jedrychowski MP, Moore CS, Cialic R, Lanser AJ, et al. 2014. Identification of a unique TGF-β-dependent molecular and functional signature in microglia. Nat. Neurosci. 17:131-43
38. Gosselin D, Link VM, Romanoski CE, Fonseca GJ, Eichenfield DZ, et al. 2014. Environment drives selection and function of enhancers controlling tissue-specific macrophage identities. Cell 159:1327-40
39. Zhang Y, Chen K, Sloan SA, Bennett ML, Scholze AR, et al. 2014. An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J. Neurosci. 34:11929-47
40. Hickman SE, Kingery ND, Ohsumi TK, Borowsky ML, Wang LC, et al. 2013. The microglial sensome revealed by direct RNA sequencing. Nat. Neurosci. 16:1896-905
41. Ransohoff RM. 2016. A polarizing question: Do M1 and M2 microglia exist? Nat. Neurosci. 19:987-91
42. Chiu IM, Morimoto ET, Goodarzi H, Liao JT, O'Keeffe S, et al. 2013. A neurodegeneration-specific gene-expression signature of acutely isolated microglia from an amyotrophic lateral sclerosis mouse model. Cell Rep. 4:385-401
43. Abutbul S, Shapiro J, Szaingurten-Solodkin I, Levy N, Carmy Y, et al. 2012. TGF-beta signaling through SMAD2/3 induces the quiescent microglial phenotype within the CNS environment. Glia 60:1160-71
44. Matcovitch-Natan O, Winter DR, Giladi A, Vargas Aguilar S, Spinrad A, et al. 2016. Microglia development follows a stepwise program to regulate brain homeostasis. Science 353:789-801
45. Grabert K, Michoel T, Karavolos MH, Clohisey S, Baillie JK, et al. 2016. Microglial brain regiondependent diversity and selective regional sensitivities to aging. Nat. Neurosci. 19:504-16
46. Hoban AE, Stilling RM, Ryan FJ, Shanahan F, Dinan TG, et al. 2016. Regulation of prefrontal cortex myelination by the microbiota. Transl. Psychiatry 6:e774
47. Ogbonnaya ES, Clarke G, Shanahan F, Dinan TG, Cryan JF, O'Leary OF. 2015. Adult hippocampal neurogenesis is regulated by the microbiome. Biol. Psychiatry 78:e7-9
48. Mayer EA, Knight R, Mazmanian SK, Cryan JF, Tillisch K. 2014. Gutmicrobes and the brain: paradigm shift in neuroscience. J. Neurosci. 34:15490-96
49. Marshall JK, Thabane M, Garg AX, Clark WF, Moayyedi P, Collins SM. 2010. Eight year prognosis of postinfectious irritable bowel syndrome following waterborne bacterial dysentery. Gut 59:605-11
50. Yano JM, Yu K, Donaldson GP, Shastri GG, Ann P, et al. 2015. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell 161:264-76
51. Braniste V, Al-Asmakh M, Kowal C, Anuar F, Abbaspour A, et al. 2014. The gut microbiota influences blood-brain barrier permeability in mice. Sci. Transl. Med. 6:263ra158
52. Erny D, Hrabe de Angelis AL, Jaitin D, Wieghofer P, Staszewski O, et al. 2015. Host microbiota constantly control maturation and function of microglia in the CNS. Nat. Neurosci. 18:965-77
53. Villa A, Vegeto E, Poletti A, Maggi A. 2016. Estrogens, neuroinflammation, and neurodegeneration. Endocr. Rev. 37:372-402
54. Schwarz JM, Bilbo SD. 2012. Sex, glia, and development: interactions in health and disease. Horm. Behav. 62:243-53
55. Lenz KM, Nugent BM, McCarthy MM. 2012. Sexual differentiation of the rodent brain: dogma and beyond. Front. Neurosci. 6:26
56. Tremblay ME, Zettel ML, Ison JR, Allen PD, Majewska AK. 2012. Effects of aging and sensory loss on glial cells in mouse visual and auditory cortices. Glia 60:541-58
57. Poliani PL, Wang Y, Fontana E, Robinette ML, Yamanishi Y, et al. 2015. TREM2 sustains microglial expansion during aging and response to demyelination. J. Clin. Investig. 125:2161-70
58. Sierra A, Gottfried-Blackmore AC, McEwen BS, Bulloch K. 2007. Microglia derived from aging mice exhibit an altered inflammatory profile. Glia 55:412-24
59. Hefendehl JK, Neher JJ, Suhs RB, Kohsaka S, Skodras A, Jucker M. 2014. Homeostatic and injuryinduced microglia behavior in the aging brain. Aging Cell 13:60-69
60. Safaiyan S, Kannaiyan N, Snaidero N, Brioschi S, Biber K, et al. 2016. Age-related myelin degradation burdens the clearance function of microglia during aging. Nat. Neurosci. 19:995-98
61. Squarzoni P, Thion MS, Garel S. 2015. Neuronal and microglial regulators of cortical wiring: usual and novel guideposts. Front. Neurosci. 9:248
62. Arno B, Grassivaro F, Rossi C, Bergamaschi A, Castiglioni V, et al. 2014. Neural progenitor cells orchestrate microglia migration and positioning into the developing cortex. Nat. Commun. 5:5611
63. Li Y, Du XF, Du JL. 2013. Resting microglia respond to and regulate neuronal activity in vivo. Commun. Integr. Biol. 6:e24493
64. Luo C, Koyama R, Ikegaya Y. 2016. Microglia engulf viable newborn cells in the epileptic dentate gyrus. Glia 64:1508-17
65. Solano Fonseca R, Mahesula S, Apple DM, Raghunathan R, Dugan A, et al. 2016. Neurogenic niche microglia undergo positional remodeling and progressive activation contributing to age-associated reductions in neurogenesis. Stem Cells Dev. 25:542-55
66. Kettenmann H, Kirchhoff F, Verkhratsky A. 2013. Microglia: new roles for the synaptic stripper. Neuron 77:10-18
67. Tremblay ME, Stevens B, Sierra A, Wake H, Bessis A, Nimmerjahn A. 2011. The role of microglia in the healthy brain. J. Neurosci. 31:16064-69
68. Schafer DP, Lehrman EK, Kautzman AG, Koyama R, Mardinly AR, et al. 2012. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron 74:691-705
69. Stevens B, Allen NJ, Vazquez LE, Howell GR, Christopherson KS, et al. 2007. The classical complement cascade mediates CNS synapse elimination. Cell 131:1164-78
70. Bialas AR, Stevens B. 2013. TGF-beta signaling regulates neuronal C1q expression and developmental synaptic refinement. Nat. Neurosci. 16:1773-82
71. Paolicelli RC, Bolasco G, Pagani F, Maggi L, Scianni M, et al. 2011. Synaptic pruning by microglia is necessary for normal brain development. Science 333:1456-58
72. Hoshiko M, Arnoux I, Avignone E, Yamamoto N, Audinat E. 2012. Deficiency of the microglial receptor CX3CR1 impairs postnatal functional development of thalamocortical synapses in the barrel cortex. J. Neurosci. 32:15106-11
73. Vezzani A, Viviani B. 2015. Neuromodulatory properties of inflammatory cytokines and their impact on neuronal excitability. Neuropharmacology 96:70-82
74. Paulsen O, Sejnowski TJ. 2000. Natural patterns of activity and long-term synaptic plasticity. Curr. Opin. Neurobiol. 10:172-79
75. Collingridge GL, Peineau S. 2014. Strippers reveal their depressing secrets: removing AMPA receptors. Neuron 82:3-6
76. Zhang J, Malik A, Choi HB, Ko RW, Dissing-Olesen L, MacVicar BA. 2014. Microglial CR3 activation triggers long-term synaptic depression in the hippocampus via NADPH oxidase. Neuron 82:195-207
77. Parkhurst CN, Yang G, Ninan I, Savas JN, Yates JR 3rd, et al. 2013. Microglia promote learningdependent synapse formation through brain-derived neurotrophic factor. Cell 155:1596-609
78. Tong L, Prieto GA, Kramar EA, Smith ED, Cribbs DH, et al. 2012. Brain-derived neurotrophic factordependent synaptic plasticity is suppressed by interleukin-1βvia p38 mitogen-activated protein kinase. J. Neurosci. 32:17714-24
79. Lynch MA. 2015. Neuroinflammatory changes negatively impact on LTP: a focus on IL-1β. Brain Res. 1621:197-204
80. Coull JA, Beggs S, Boudreau D, Boivin D, Tsuda M, et al. 2005. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 438:1017-21
81. Stellwagen D, Malenka RC. 2006. Synaptic scaling mediated by glial TNF-alpha. Nature 440:1054-59
82. Pascual O, Ben Achour S, Rostaing P, Triller A, Bessis A. 2012. Microglia activation triggers astrocytemediated modulation of excitatory neurotransmission. PNAS 109:E197-205
83. Dissing-Olesen L, LeDue JM, Rungta RL, Hefendehl JK, Choi HB, MacVicar BA. 2014. Activation of neuronal NMDA receptors triggers transient ATP-mediated microglial process outgrowth. J. Neurosci. 34:10511-27
84. Masuch A, Shieh CH, van Rooijen N, van Calker D, Biber K. 2016. Mechanism of microglia neuroprotection: involvement of P2X7, TNFa, and valproic acid. Glia 64:76-89
85. Kato G, Inada H, Wake H, Akiyoshi R, Miyamoto A, et al. 2016. Microglial contact prevents excess depolarization and rescues neurons from excitotoxicity. eNeuro 3:e0004-16.2016
86. Barres BA. 2008. Themystery andmagic of glia: a perspective on their roles in health and disease. Neuron 60:430-40
87. Rothstein JD, Dykes-Hoberg M, Pardo CA, Bristol LA, Jin L, et al. 1996. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16:675-86
88. Christian CA, Huguenard JR. 2013. Astrocytes potentiate GABAergic transmission in the thalamic reticular nucleus via endozepine signaling. PNAS 110:20278-83
89. Lee M, Schwab C, McGeer PL. 2011. Astrocytes are GABAergic cells that modulate microglial activity. Glia 59:152-65
90. Min KJ, Yang MS, Kim SU, Jou I, Joe EH. 2006. Astrocytes induce hemeoxygenase-1 expression in microglia: a feasible mechanism for preventing excessive brain inflammation. J. Neurosci. 26:1880-87
91. Welser-Alves JV, Crocker SJ, Milner R. 2011. A dual role for microglia in promoting tissue inhibitor of metalloproteinase (TIMP) expression in glial cells in response to neuroinflammatory stimuli. J. Neuroinflammation 8:61
92. Mohri I, Taniike M, Taniguchi H, Kanekiyo T, Aritake K, et al. 2006. Prostaglandin D2-mediated microglia/astrocyte interaction enhances astrogliosis and demyelination in twitcher. J. Neurosci. 26:4383-93
93. Kranich J, Krautler NJ, Falsig J, Ballmer B, Li S, et al. 2010. Engulfment of cerebral apoptotic bodies controls the course of prion disease in a mouse strain-dependent manner. J. Exp. Med. 207:2271-81
94. Walker LC, Jucker M. 2015. Neurodegenerative diseases: expanding the prion concept. Annu. Rev. Neurosci. 38:87-103
95. De Strooper B, Karran E. 2016. The cellular phase of Alzheimer's disease. Cell 164:603-15
96. Basso M, Bonetto V. 2016. Extracellular vesicles and a novel form of communication in the brain. Front. Neurosci. 10:127
97. Brites D, Fernandes A. 2015. Neuroinflammation and depression: microglia activation, extracellular microvesicles and microRNA dysregulation. Front. Cell. Neurosci. 9:476
98. Zhu C, Herrmann US, Falsig J, Abakumova I, Nuvolone M, et al. 2016. A neuroprotective role for microglia in prion diseases. J. Exp. Med. 213:1047-59
99. Hughes MM, Field RH, Perry VH, Murray CL, Cunningham C. 2010. Microglia in the degenerating brain are capable of phagocytosis of beads and of apoptotic cells, but do not efficiently remove PrPSc, even upon LPS stimulation. Glia 58:2017-30
100. Tanzi RE. 2012. The genetics of Alzheimer disease. Cold Spring Harb. Perspect. Med. 2:a006296
101. Hyman BT, Holtzman DM. 2015. Apolipoprotein E levels and Alzheimer risk. Ann. Neurol. 77:204-5
102. Terwel D, Steffensen KR, Verghese PB, Kummer MP, Gustafsson JA, et al. 2011. Critical role of astroglial apolipoprotein E and liver X receptor-aexpression formicroglial Aβphagocytosis. J. Neurosci. 31:7049-59
103. Cramer PE, Cirrito JR, Wesson DW, Lee CY, Karlo JC, et al. 2012. ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models. Science 335:1503-6
104. Mandrekar-Colucci S, Karlo JC, Landreth GE. 2012. Mechanisms underlying the rapid peroxisome proliferator-activated receptor-gamma-mediated amyloid clearance and reversal of cognitive deficits in a murine model of Alzheimer's disease. J. Neurosci. 32:10117-28
105. El Khoury JB, Moore KJ, Means TK, Leung J, Terada K, et al. 2003. CD36 mediates the innate host response to β-amyloid. J. Exp. Med. 197:1657-66
106. Heneka MT, Kummer MP, Stutz A, Delekate A, Schwartz S, et al. 2013. NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice. Nature 493:674-78
107. Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, et al. 2013. TREM2 variants in Alzheimer's disease. N. Engl. J. Med. 368:117-27
108. Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, et al. 2013. Variant of TREM2 associated with the risk of Alzheimer's disease. N. Engl. J. Med. 368:107-16
109. Bertram L, Lange C, Mullin K, Parkinson M, Hsiao M, et al. 2008. Genome-wide association analysis reveals putativeAlzheimer's disease susceptibility loci in addition toAPOE. Am. J.Hum.Genet. 83:623-32
110. Lambert JC, Heath S, Even G, Campion D, Sleegers K, et al. 2009. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat. Genet. 41:1094-99
111. Ford JW, McVicar DW. 2009. TREM and TREM-like receptors in inflammation and disease. Curr. Opin. Immunol. 21:38-46
112. Xing J, Titus AR, Humphrey MB. 2015. The TREM2-DAP12 signaling pathway in Nasu-Hakola disease: a molecular genetics perspective. Res. Rep. Biochem. 5:89-100
113. Peng Q, Malhotra S, Torchia JA, Kerr WG, Coggeshall KM, Humphrey MB. 2010. TREM2-and DAP12-dependent activation of PI3K requires DAP10 and is inhibited by SHIP1. Sci. Signal. 3:ra38
114. Wang Y, Cella M, Mallinson K, Ulrich JD, Young KL, et al. 2015. TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model. Cell 160:1061-71
115. Song W, Hooli B, Mullin K, Jin SC, Cella M, et al. 2016. Alzheimer's disease-associatedTREM2variants exhibit either decreased or increased ligand-dependent activation. Alzheimers Dement. In press. https:// doi.org/10.1016/j.jalz.2016.07.004
116. Yeh FL, Wang Y, Tom I, Gonzalez LC, Sheng M. 2016. TREM2 binds to apolipoproteins, including APOE and CLU/APOJ, and thereby facilitates uptake of amyloid-beta by microglia. Neuron 91:328-40
117. Atagi Y, Liu CC, Painter MM, Chen XF, Verbeeck C, et al. 2015. Apolipoprotein E is a ligand for triggering receptor expressed on myeloid cells 2 (TREM2). J. Biol. Chem. 290:26043-50
118. Bailey CC, DeVaux LB, Farzan M. 2015. The triggering receptor expressed on myeloid cells 2 binds apolipoprotein E. J. Biol. Chem. 290:26033-42
119. Otero K, Turnbull IR, Poliani PL, Vermi W, Cerutti E, et al. 2009. Macrophage colony-stimulating factor induces the proliferation and survival of macrophages via a pathway involving DAP12 and betacatenin. Nat. Immunol. 10:734-43
120. Hsieh CL, Koike M, Spusta SC, Niemi EC, Yenari M, et al. 2009. A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia. J. Neurochem. 109:1144-56
121. Takahashi K, Prinz M, Stagi M, Chechneva O, Neumann H. 2007. TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis. PLOS Med. 4:e124
122. Takahashi K, Rochford CD, Neumann H. 2005. Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J. Exp. Med. 201:647-57
123. Turnbull IR, Gilfillan S, Cella M, Aoshi T, Miller M, et al. 2006. Cutting edge: TREM-2 attenuates macrophage activation. J. Immunol. 177:3520-24
124. Hamerman JA, Jarjoura JR, Humphrey MB, Nakamura MC, Seaman WE, Lanier LL. 2006. Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed onmyeloid cells (TREM)-2 and DAP12. J. Immunol. 177:2051-55
125. Kober DL, Alexander-Brett JM, Karch CM, Cruchaga C, Colonna M, et al. 2016. Neurodegenerative disease mutations in TREM2 reveal a functional surface and distinct loss-of-function mechanisms. eLife 5:e20391
126. Paloneva J, Manninen T, Christman G, Hovanes K, Mandelin J, et al. 2002. Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype. Am. J. Hum. Genet. 71:656-62
127. Paloneva J, Autti T, Hakola P, Haltia MJ. 2002. Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL). GeneReviews, updated Mar. 12, 2015, Univ. Wash., Seattle. https:// www.ncbi.nlm.nih.gov/books/NBK1197/
128. Ulrich JD, Finn MB, Wang Y, Shen A, Mahan TE, et al. 2014. Alteredmicroglial response to Aβplaques in APPPS1-21 mice heterozygous for TREM2. Mol. Neurodegener. 9:20
129. Jay TR, Miller CM, Cheng PJ, Graham LC, Bemiller S, et al. 2015. TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer's disease mouse models. J. Exp. Med. 212:287-95
130. Wang Y, Ulland TK, Ulrich JD, Song W, Tzaferis JA, et al. 2016. TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques. J. Exp. Med. 213:667-75
131. Yuan P, Condello C, Keene CD, Wang Y, Bird TD, et al. 2016. TREM2 haplodeficiency in mice and humans impairs the microglia barrier function leading to decreased amyloid compaction and severe axonal dystrophy. Neuron 90:724-39
132. Jay TR, Hirsch AM, Broihier ML, Miller CM, Neilson LE, et al. 2017. Disease progression-dependent effects of TREM2 deficiency in a mouse model of Alzheimer's disease. J. Neurosci. 37:637-47
133. Kleinberger G, Yamanishi Y, Suarez-Calvet M, Czirr E, Lohmann E, et al. 2014. TREM2mutations implicated in neurodegeneration impair cell surface transport and phagocytosis. Sci. Transl.Med. 6:243ra86
134. Wunderlich P, Glebov K, Kemmerling N, Tien NT, Neumann H, Walter J. 2013. Sequential proteolytic processing of the triggering receptor expressed on myeloid cells-2 (TREM2) protein by ectodomain shedding and gamma-secretase-dependent intramembranous cleavage. J. Biol. Chem. 288:33027-36
135. Suarez-Calvet M, Kleinberger G, Araque Caballero MA, Brendel M, Rominger A, et al. 2016. sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers. EMBO Mol. Med. 8:466-76
136. Piccio L, Deming Y, Del-Aguila JL, Ghezzi L, Holtzman DM, et al. 2016. Cerebrospinal fluid soluble TREM2is higher in Alzheimer disease and associated with mutation status. Acta Neuropathol. 131:925-33
137. Bradshaw EM, Chibnik LB, Keenan BT, Ottoboni L, Raj T, et al. 2013. CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology. Nat. Neurosci. 16:848-50
138. Griciuc A, Serrano-Pozo A, Parrado AR, Lesinski AN, Asselin CN, et al. 2013. Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta. Neuron 78:631-43
139. Hong S, Beja-Glasser VF, Nfonoyim BM, Frouin A, Li S, et al. 2016. Complement andmicroglia mediate early synapse loss in Alzheimer mouse models. Science 352:712-16
140. Britschgi M, Takeda-Uchimura Y, Rockenstein E, Johns H, Masliah E, Wyss-Coray T. 2012. Deficiency of terminal complement pathway inhibitor promotes neuronal Tau pathology and degeneration in mice. J. Neuroinflammation 9:220
141. Killick R, Hughes TR, Morgan BP, Lovestone S. 2013. Deletion of Crry, the murine ortholog of the sporadic Alzheimer's disease risk gene CR1, impacts Tau phosphorylation and brain CFH. Neurosci. Lett. 533:96-99
142. Fonseca MI, Chu S, Pierce AL, Brubaker WD, Hauhart RE, et al. 2016. Analysis of the putative role of CR1 in Alzheimer's disease: genetic association, expression and function. PLOS One 11:e0149792
143. Simard AR, Soulet D, Gowing G, Julien JP, Rivest S. 2006. Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron 49:489-502
144. El Khoury J, Toft M, Hickman SE, Means TK, Terada K, et al. 2007. Ccr2 deficiency impairsmicroglial accumulation and accelerates progression of Alzheimer-like disease. Nat. Med. 13:432-38
145. Hawkes CA, McLaurin J. 2009. Selective targeting of perivascular macrophages for clearance of betaamyloid in cerebral amyloid angiopathy. PNAS 106:1261-66
146. Mildner A, Schmidt H, Nitsche M, Merkler D, Hanisch UK, et al. 2007. Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions. Nat. Neurosci. 10:1544-53
147. Ajami B, Bennett JL, Krieger C, Tetzlaff W, Rossi FM. 2007. Local self-renewal can sustain CNS microglia maintenance and function throughout adult life. Nat. Neurosci. 10:1538-43
148. Renton AE, Chio A, Traynor BJ. 2014. State of play in amyotrophic lateral sclerosis genetics. Nat. Neurosci. 17:17-23
149. Beers DR, Henkel JS, Xiao Q, Zhao W, Wang J, et al. 2006. Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. PNAS 103:16021-26
150. Boillee S, Yamanaka K, Lobsiger CS, Copeland NG, Jenkins NA, et al. 2006. Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312:1389-92
151. Frakes AE, Ferraiuolo L, Haidet-Phillips AM, Schmelzer L, Braun L, et al. 2014. Microglia inducemotor neuron death via the classical NF-κB pathway in amyotrophic lateral sclerosis. Neuron 81:1009-23
152. Butovsky O, Siddiqui S, Gabriely G, Lanser AJ, Dake B, et al. 2012. Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS. J. Clin. Investig. 122:3063-87
153. O'Rourke JG, Bogdanik L, Yanez A, Lall D, Wolf AJ, et al. 2016. C9orf72 is required for proper macrophage and microglial function in mice. Science 351:1324-29
154. Lewis CA, Manning J, Rossi F, Krieger C. 2012. The neuroinflammatory response in ALS: the roles of microglia and T cells. Neurol. Res. Int. 2012:803701
155. Cady J, Koval ED, Benitez BA, Zaidman C, Jockel-Balsarotti J, et al. 2014. TREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosis. JAMA Neurol. 71:449-53
156. Cirulli ET, Lasseigne BN, Petrovski S, Sapp PC, Dion PA, et al. 2015. Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science 347:1436-41
157. Ahmad L, Zhang SY, Casanova JL, Sancho-Shimizu V. 2016. Human TBK1: a gatekeeper of neuroinflammation. Trends Mol. Med. 22:511-27
158. Daniele SG, Beraud D, Davenport C, Cheng K, Yin H, Maguire-Zeiss KA. 2015. Activation of MyD88-dependent TLR1/2 signaling by misfolded alpha-synuclein, a protein linked to neurodegenerative disorders. Sci. Signal. 8:ra45
159. Kumaran R, Cookson MR. 2015. Pathways to Parkinsonism Redux: convergent pathobiological mechanisms in genetics of Parkinson's disease. Hum. Mol. Genet. 24:R32-44
160. Daher JP, Volpicelli-Daley LA, Blackburn JP, Moehle MS, West AB. 2014. Abrogation of alphasynuclein-mediated dopaminergic neurodegeneration in LRRK2-deficient rats. PNAS 111:9289-94
161. Rayaprolu S, Mullen B, Baker M, Lynch T, Finger E, et al. 2013. TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease. Mol. Neurodegener. 8:19
162. Cardona AE, Pioro EP, Sasse ME, Kostenko V, Cardona SM, et al. 2006. Control of microglial neurotoxicity by the fractalkine receptor. Nat. Neurosci. 9:917-24
163. Ellrichmann G, Reick C, Saft C, Linker RA. 2013. The role of the immune system in Huntington's disease. Clin. Dev. Immunol. 2013:541259
164. Tai YF, Pavese N, Gerhard A, Tabrizi SJ, Barker RA, et al. 2007. Microglial activation in presymptomatic Huntington's disease gene carriers. Brain 130:1759-66
165. Miller JR, Lo KK, Andre R, Hensman Moss DJ, Trager U, et al. 2016. RNA-Seq of Huntington's disease patient myeloid cells reveals innate transcriptional dysregulation associated with proinflammatory pathway activation. Hum. Mol. Genet. 25:2893-904
166. Connolly C, Magnusson-Lind A, Lu G, Wagner PK, Southwell AL, et al. 2016. Enhanced immune response to MMP3 stimulation in microglia expressing mutant huntingtin. Neuroscience 325:74-88
167. Miller JP, Holcomb J, Al-Ramahi I, de Haro M, Gafni J, et al. 2010. Matrix metalloproteinases are modifiers of huntingtin proteolysis and toxicity in Huntington's disease. Neuron 67:199-212
168. Quigley HA. 2011. Glaucoma. Lancet 377:1367-77
169. Nussenblatt RB, Liu B, Li Z. 2009. Age-related macular degeneration: an immunologically driven disease. Curr. Opin. Investig. Drugs 10:434-42
170. Vohra R, Tsai JC, Kolko M. 2013. The role of inflammation in the pathogenesis of glaucoma. Surv. Ophthalmol. 58:311-20
171. Buschini E, Piras A, Nuzzi R, Vercelli A. 2011. Age related macular degeneration and drusen: neuroinflammation in the retina. Prog. Neurobiol. 95:14-25
172. Karlstetter M, Ebert S, Langmann T. 2010. Microglia in the healthy and degenerating retina: insights from novel mouse models. Immunobiology 215:685-91
173. Bringmann A, Wiedemann P. 2012. Muller glial cells in retinal disease. Ophthalmologica 227:1-19
174. Madeira MH, Boia R, Elvas F, Martins T, Cunha RA, et al. 2016. Selective A2A receptor antagonist prevents microglia-mediated neuroinflammation and protects retinal ganglion cells from high intraocular pressure-induced transient ischemic injury. Transl. Res. 169:112-28
175. Chen SK, Tvrdik P, Peden E, Cho S, Wu S, et al. 2010. Hematopoietic origin of pathological grooming in Hoxb8 mutant mice. Cell 141:775-85
176. Yasui DH, Xu H, Dunaway KW, Lasalle JM, Jin LW, Maezawa I. 2013. MeCP2 modulates gene expression pathways in astrocytes. Mol. Autism 4:3
177. Cronk JC, Derecki NC, Ji E, Xu Y, Lampano AE, et al. 2015. Methyl-CpG binding protein 2 regulates microglia and macrophage gene expression in response to inflammatory stimuli. Immunity 42:679-91
178. Derecki NC, Cronk JC, Lu Z, Xu E, Abbott SB, et al. 2012. Wild-type microglia arrest pathology in a mouse model of Rett syndrome. Nature 484:105-9
179. Wang J, Wegener JE, Huang TW, Sripathy S, De Jesus-Cortes H, et al. 2015. Wild-type microglia do not reverse pathology in mouse models of Rett syndrome. Nature 521:E1-4
180. Schafer DP, Heller CT, Gunner G, Heller M, Gordon C, et al. 2016. Microglia contribute to circuit defects in Mecp2 null mice independent of microglia-specific loss of Mecp2 expression. eLife 5:e15224
181. Steiner J, Bielau H, Brisch R, Danos P, Ullrich O, et al. 2008. Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide. J. Psychiatr. Res. 42:151-57
182. Steiner J, Walter M, Gos T, Guillemin GJ, Bernstein HG, et al. 2011. Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission? J. Neuroinflammation 8:94
183. Torres-Platas SG, Cruceanu C, Chen GG, Turecki G, Mechawar N. 2014. Evidence for increased microglial priming and macrophage recruitment in the dorsal anterior cingulatewhite matter of depressed suicides. Brain Behav. Immun. 42:50-59
184. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. 2008. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 9:46-56
185. Yirmiya R, Rimmerman N, Reshef R. 2015. Depression as amicroglial disease. TrendsNeurosci. 38:637-58
186. Shinjo R, Imagama S, Ito Z, Ando K, Nishida Y, et al. 2014. Keratan sulfate expression is associated with activation of a subpopulation of microglia/macrophages in Wallerian degeneration. Neurosci. Lett. 579:80-85
187. Doty KR, Guillot-Sestier MV, Town T. 2015. The role of the immune system in neurodegenerative disorders: Adaptive or maladaptive? Brain Res. 1617:155-73
188. Wisniewski T, Goni F. 2015. Immunotherapeutic approaches for Alzheimer's disease. Neuron 85:1162-76
189. Sevigny J, Chiao P, Bussiere T, Weinreb PH, Williams L, et al. 2016.The antibody aducanumab reduces Aβplaques in Alzheimer's disease. Nature 537:50-56
190. Xiang X, Werner G, Bohrmann B, Liesz A, Mazaheri F, et al. 2016. TREM2 deficiency reduces the efficacy of immunotherapeutic amyloid clearance. EMBO Mol. Med. 8:992-1004
191. Spangenberg EE, Green KN. 2017. Inflammation in Alzheimer's disease: lessons learned frommicrogliadepletion models. Brain Behav. Immun. 61:1-11
192. Olmos-Alonso A, Schetters ST, Sri S, Askew K, Mancuso R, et al. 2016. Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer's-like pathology. Brain 139:891-907
193. Chitu V, Gokhan S, Gulinello M, Branch CA, Patil M, et al. 2015. Phenotypic characterization of a Csf1r haploinsufficient mouse model of adult-onset leukodystrophy with axonal spheroids and pigmented glia (ALSP). Neurobiol. Dis. 74:219-28
194. Luo J, Elwood F, Britschgi M, Villeda S, Zhang H, et al. 2013. Colony-stimulating factor 1 receptor (CSF1R) signaling in injured neurons facilitates protection and survival. J. Exp. Med. 210:157-72
195. Daneschvar HL, Aronson MD, Smetana GW. 2015. Do statins prevent Alzheimer's disease? A narrative review. Eur. J. Intern. Med. 26:666-69
196. Jin G, Bai D, Yin S, Yang Z, Zou D, et al. 2016. Silibinin rescues learning and memory deficits by attenuating microglia activation and preventing neuroinflammatory reactions in SAMP8 mice. Neurosci. Lett. 629:256-61
197. Savage JC, Jay T, Goduni E, Quigley C, Mariani MM, et al. 2015. Nuclear receptors license phagocytosis by TREM2+ myeloid cells in mouse models of Alzheimer's disease. J. Neurosci. 35:6532-43
198. Luz I, Liraz O, Michaelson DM. 2016. An anti-apoE4 specific monoclonal antibody counteracts the pathological effects of apoE4 in vivo. Curr. Alzheimer Res. 13:918-29
199. Nixon RA, Yang DS. 2012. Autophagy and neuronal cell death in neurological disorders. Cold Spring Harb. Perspect. Biol. 4:a008839
200. Cho MH, Cho K, Kang HJ, Jeon EY, Kim HS, et al. 2014. Autophagy inmicroglia degrades extracellular beta-amyloid fibrils and regulates the NLRP3 inflammasome. Autophagy 10:1761-75
201. Kim HJ, Cho MH, Shim WH, Kim JK, Jeon EY, et al. 2016. Deficient autophagy in microglia impairs synaptic pruning and causes social behavioral defects. Mol. Psychiatry. In press. https://doi.org/ 10.1038/mp.2016.103
202. Varvel NH, Grathwohl SA, Degenhardt K, Resch C, Bosch A, et al. 2015. Replacement of brain-resident myeloid cells does not alter cerebral amyloid-beta deposition in mouse models of Alzheimer's disease. J. Exp. Med. 212:1803-9
203. Prokop S, Miller KR, Drost N, Handrick S, Mathur V, et al. 2015. Impact of peripheral myeloid cells on amyloid-beta pathology in Alzheimer's disease-like mice. J. Exp. Med. 212:1811-18